{"id":"W4399048108","doi":"10.1002/jpn3.12252","title":"Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long‐term extension results","year":2024,"lang":"en","type":"article","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Janssen Research and Development; Janssen Scientific Affairs; Hospital for Sick Children; F. Hoffmann-La Roche; Pfizer; Celgene; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Medicine; Ustekinumab; Adverse effect; Internal medicine; Dosing; Crohn's disease; Randomization; Clinical trial; Gastroenterology; Pediatrics; Disease; Adalimumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002513236,0.0006185866,0.00155274,0.0001646388,0.0001990468,0.0004941935,0.0004811129,0.0006749517,0.001550228],"category_scores_gemma":[0.001224336,0.0003274435,0.001281222,0.0003020606,0.0004822233,0.0005422132,0.000498472,0.001557144,0.0003747662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003462434,"about_ca_system_score_gemma":0.0009075376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003684339,"about_ca_topic_score_gemma":0.0009597537,"domain_scores_codex":[0.9991474,0.0005512837,0.00006340001,0.00007677945,0.00009181903,0.00006927263],"domain_scores_gemma":[0.998515,0.000254193,0.0005802284,0.0001374626,0.0001081959,0.0004048801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8089432,0.01124355,0.05245456,0.002607825,0.002282824,0.0005547652,0.0004163752,0.00158692,0.01773124,0.0002464821,0.002848994,0.09908325],"study_design_scores_gemma":[0.4241006,0.3983605,0.1629573,0.0003101502,0.001993152,0.00156642,0.0001159701,0.0007746592,0.002875629,0.0001330583,0.006768762,0.00004382152],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913812,0.0064348,0.0001972879,0.0001626104,0.00004027816,0.0004213829,0.000616223,0.00002581805,0.000720294],"genre_scores_gemma":[0.9911863,0.003868632,0.001103705,0.0003751365,0.0001407121,0.0007637739,0.0017584,0.00001405683,0.0007892005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002513236,"threshold_uncertainty_score":0.01329136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005860392376697283,"score_gpt":0.2302749463320534,"score_spread":0.2244145539553561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}